RISE Life Science Corp., headquartered in California, is a prominent player in the life sciences industry, specialising in innovative cannabis-based products. Founded in 2017, the company has rapidly established itself as a leader in the development of health and wellness solutions, focusing on the therapeutic benefits of cannabinoids. With a diverse portfolio that includes unique formulations for pain relief, sleep enhancement, and overall wellness, RISE Life Science distinguishes itself through its commitment to quality and scientific research. The company operates primarily in North America, leveraging its expertise to meet the growing demand for natural health alternatives. Notable achievements include strategic partnerships and a robust market presence, positioning RISE Life Science as a trusted name in the evolving landscape of cannabis health products.
How does RISE Life Science Corp.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
RISE Life Science Corp.'s score of 23 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
RISE Life Science Corp., headquartered in California, currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of reported figures. The company is classified as a merged entity, and any potential emissions data may be inherited from its corporate family, but no specific details or figures have been provided. In terms of climate commitments, RISE Life Science Corp. has not outlined any reduction targets or initiatives, nor does it appear to have adopted any specific climate pledges or frameworks such as the Science Based Targets initiative (SBTi). This lack of publicly available information suggests that the company may still be in the early stages of developing its climate strategy. As the industry increasingly prioritises sustainability and carbon reduction, RISE Life Science Corp. will need to establish clear emissions reporting and reduction commitments to align with best practices and stakeholder expectations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
RISE Life Science Corp. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
